‌

US Patent 12060330 Therapeutic indazoles

Patent 12060330 was granted and assigned to Rutgers, the State University of New Jersey on August, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Rutgers, the State University of New Jersey

Current Assignee

Rutgers, the State University of New Jersey

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120603300

Patent Inventor Names

Sean Ekins0

David Alland0

Divya Awasthi0

Pradeep Kumar0

Matthew B. Neiditch0

Glenn Capodagli0

Joel S. Freundlich0

Date of Patent

August 13, 2024

Patent Application Number

175175690

Date Filed

November 2, 2021

Patent Citations

‌

US Patent 9718840 Condensed 5-oxazolidinone derivative

‌

US Patent 7199147 Rho kinase inhibitors

‌

US Patent 7217722 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same

‌

US Patent 8772305 Substituted pyridinyl-pyrimidines and their use as medicaments

‌

US Patent 11186549 Therapeutic indazoles

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12060330 Therapeutic indazoles

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API